Main > A1. CORP. INDEX. B-Bm > Bayer AG./P C2
Bayer AG./P C2's subsections
1997. 01.29.1997. (Isocyanurate CL)
1997. 07.04.1997. (Ion Exch. Resin)
2002. 02.25.2002. (BioDeg Polymer)
2002. 03.18.2002. (Business Sale)
2002. 04.01.2002. (Polyurethane)
2002. 04.22.2002. (Generics)
2002. 05.06.2002. (Pigments)
2002. 05.06.2002. (PU Dispersion)
2002. 05.13.2002. (Malaria)
2002. 05.13.2002. (OLED Pact)
2002. 05.20.2002. (Fine Chemical)
2002. 05.20.2002. (TDI Precursor)
2002. 05.27.2002. (Sports/PU)
2002. 06.10.2002. (Fine Chemical)
2002. 06.24.2002. (Partner in)
2002. 07.22.2002. (Corp. Sale)
2002. 07.22.2002. (Fine Chemical)
2002. 07.29.2002. (AIDS Diag.)
2002. 07.29.2002. (Corp. Acq.)
2002. 08.26.2002. (Financial Cert.)
2002. 09.23.2002. (Antibiotics)
2002. 09.23.2002. (Business Sale)
2002. 09.23.2002. (Colorants)
2002. 09.23.2002. (ImPotency)
2002. 09.30.2002. (Aro HydroxyAcid)
2002. 09.30.2002. (Business Sale)
2002. 09.30.2002. (Chiral Hydrog.)
2002. 10.14.2002. (Asthma Rights)
2002. 10.14.2002. (Parent of)
2002. 10.21.2002. (Business Sale)
2002. 10.21.2002. (Corp. Acq.)
2002. 10.28.2002. (ImPotency)
2002. 10.28.2002. (Lipobay)
2002. 11.11.2002. (NCMC Member)
2002. 11.25.2002. (ImPotency)
2002. 12.02.2002. (ImPotency)
2002. 12.16.2002. (Business Acq.)
2002. 12.23.2002. (Textiles)
2003. 01.13.2003. (Textiles)
2003. 02.17.2003. (Executive)
2003. 02.17.2003. (Fine Chemical)
2003. 03.03.2003. (Baycol cases)
2003. 03.03.2003. (Executive)
2003. 03.24.2003. (Baycol cases)
2003. 04.07.2003. (JV PU House)
2003. 04.07.2003. (Logistics)
2003. 04.21.2003. (Pharma Synth.)
2003. 05.05.2003. (Chiral Pharma)
2003. 06.25.2003. (Parent of)
2003. 08.21.2003. (ImPotency)
2003. 09.01.2003. (NanoTech.)
2003. 09.01.2003. (NanoTech.)
2003. 10.06.2003. (Business Sale)
2003. 11.17.2003. (Executive)
2003. 11.17.2003. (SMB Chiral Sepn)
2004. 03.15.2004. (Chiral Het Cat.)
2005. 05.30.2005. (MicroChemistry)
2005. 07.18.2005. (Shell>DMC)
2007. 11.26.2007. (Climate Change)
2008. 03.03.2008. (Catalysis)
2008. 06.30.2008. (Brazil)
2011. 12.20.2011. Pharma. 4 BlockB
2012. 05.02.2012. RWTH Aachen
2012. 06.13.2012. Sr Bayer Rep. USA
2013. 06.05.2013. Corp. Acq.
2014. 05.06. Merck & Co.
2014. 09.18. Focus: Life Science
2015. 06.10. Divest Diabetes Care
2015. 12.21. Crispr Therapeutics JV
2016. 02.03. Hemophilia A
2016. 02.15. Acq. proPlant
2016. 04.18. IL>Trendlines
2016. 08.19. Crispr Therapeutics JV
2016. 09.14. Acq. Monsanto
2017. 02.20. Yara Intl. ASA
2017. 04.28. Onco.>Liver C.
2017. 05.08. Acq. Monsanto
2017. 08.24. Quantified Planet
2017. 09.14. Ginkgo Bioworks
2017. 11.16. PeptiDream
2018. 02.15. Mitsui
2018. 03.21. Acq. Monsanto EU OK
2018. 05.29. Acq. Monsanto USA OK
2018. 06.19. US$ Bonds
2018. 11.27. Onco.>Solid Tum USA>OK
2018. 11.29. Share: 67.86 EU
2019. 02.04. Share: 67.57 EU
2019. 07.01. Century Therapeutics
2019. 07.30. Onco.>Solid Tum CA>OK
2019. 07.31. Onco.>Prostate Cancer
2019. 08.08. Acq. BlueRock Therapeu
2019. 10.10. G4A 11 StartUps
2019. 12.12. Vet.>Dogs>Ear Drops
2019. 12.19. Onco.>Breast C.
2020. 06.24. Monsanto litigation
2020. 10.23. Onco.>Solid Tum Compan
2020. 10.26. Acq Asklepios BioPharm
2021. 06.03. Onco.>Prostate C.
2021. 07.09. Nephro.>CKD+T2D
2021. 08.05. Acq. Vividion Therap.
2022. 07.12. Allergy>USA>Available
2022. 10.26. Finerenone>CA>OK
Bayer B.V. (NL) C2
Bayer Belgique Benelux C2
Bayer Corp./P C2
Bayer CropScience/P C2
Bayer HealthCare/P C2
Bayer Inc./P C2
Bayer India Ltd./P C2
Bayer Innovation/P C2
Bayer Japan/P C2
Bayer MaterialScience/P C2
Bayer Technology Services/P C2
Web-Site
Z - OK
Bayer AG./P C2's products
This section has no products